Related Experiment Video
Updated: May 19, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Cerebrovascular consequences of pseudohyperaldosteronism
Jonathan H Smith1, Noralane M Lindor, Alejandro A Rabinstein
1Department of Neurology, Medical Genetics, Mayo Clinic, Rochester, MN 55905, USA.
Pseudohyperaldosteronism (PHA) patients experienced a 17.4% rate of cerebrovascular events. Early management of vascular risks alongside blood pressure control is crucial for PHA patients to prevent stroke.
Area of Science:
- Nephrology
- Neurology
- Cardiovascular Medicine
Background:
- Mechanistically defined hypertension offers insights into hypertension-stroke relationships.
- Pseudohyperaldosteronism (PHA) involves distal nephron epithelial sodium channel overactivation with low renin and aldosterone.
- Understanding stroke risk in rare hypertension subtypes like PHA is clinically significant.
Purpose of the Study:
- To investigate the incidence and characteristics of cerebrovascular events in patients with pseudohyperaldosteronism (PHA).
- To identify risk factors associated with stroke in this specific hypertensive cohort.
Main Methods:
- Retrospective cohort study of 23 patients diagnosed with pseudohyperaldosteronism (PHA).
- Median follow-up duration of 11 years (range: 1-30 years).
- Analysis of recorded cerebrovascular events, including type and patient demographics.
Main Results:
- A significant proportion (17.4%) of PHA patients experienced cerebrovascular events during follow-up.
- No intracranial hemorrhages were reported.
- Events were more common in older patients, minorities, those with later PHA diagnosis, and additional vascular risk factors.
Conclusions:
- Pseudohyperaldosteronism (PHA) is associated with a notable risk of cerebrovascular events.
- Strict blood pressure control is essential, but early evaluation and management of other vascular risk factors are also critical for stroke prevention in PHA.
- Further research into the specific mechanisms linking PHA to stroke may be warranted.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Hypertension II: Pathophysiology
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension III: Clinical Manifestations and Diagnostic Studies
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cytotoxic Edema: Pathophysiology

